Meten van de geactiveerde stollingstijd tijdens slagaderlijke vaatingrepen.

Measuring the ACT during Non-Cardiac arterial procedures.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON29650

Enrollment

500

Registered

2018-01-21

Start date

2016-12-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ACT

Interventions

To evaluate if the current practice of using a standardized bolus of 5000 IU of heparin during NCVI causes adequate periprocedural anticoagulation in the individual patient. This evaluation will be pe

Eligibility

Inclusion criteria

Inclusion criteria: All patients undergoing open or endovascular arterial non-cardiac arterial surgery aged more than 18 years.

Exclusion criteria

Exclusion criteria: All patients undergoing open or endovascular arterial non-cardiac arterial surgery aged younger than 18 years. Dialysis dependend or EGFR < 30 ml/min.

Design outcomes

Primary

Measure	Time frame
Percentage of patients reaching an ACT of 250 seconds by administering a standardized bolus of 5000 IU. Total dose of heparin needed to reach 250 seconds.	—

Secondary

Measure	Time frame
evaluation of predictive value of HMS to reach ACT of 250 seconds by predicted dose of heparin. All (anti)coagulation related events.	—

Contacts

Public ContactArno M. Wiersema

arno@wiersema.nu0229-208206

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)